Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pulmonx (LUNG) Income from Continuing Operations (2019 - 2025)

Pulmonx has reported Income from Continuing Operations over the past 7 years, most recently at 13957000.0 for Q3 2025.

  • Quarterly Income from Continuing Operations rose 1.38% to 13957000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 56741000.0 through Sep 2025, up 0.72% year-over-year, with the annual reading at 56394000.0 for FY2024, 7.31% up from the prior year.
  • Income from Continuing Operations was 13957000.0 for Q3 2025 at Pulmonx, up from 15196000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 10181000.0 in Q3 2021 and troughed at 16195000.0 in Q2 2023.
  • The 5-year median for Income from Continuing Operations is 14172000.0 (2022), against an average of 14131894.74.
  • Year-over-year, Income from Continuing Operations crashed 163.76% in 2021 and then grew 13.31% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 12997000.0 in 2021, then fell by 9.95% to 14290000.0 in 2022, then grew by 2.65% to 13911000.0 in 2023, then rose by 5.29% to 13175000.0 in 2024, then decreased by 5.94% to 13957000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Income from Continuing Operations are 13957000.0 (Q3 2025), 15196000.0 (Q2 2025), and 14413000.0 (Q1 2025).